Skip to main content
Caplight Logo









MabPlex International

MabPlex International

Private
YantaiHealthcare & Life Scienceshttps://www.mabplex.com/

Last Round

Series B

Jun 8, 2020

Total Funding Raised

$130.1M

Company Overview

MabPlex International is a biotechnology company that provides comprehensive contract development and manufacturing organization (CDMO) services for biologics, including monoclonal antibodies and antibody-drug conjugates.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOantibody-drug conjugatesADCbioconjugationmonoclonal antibodymAbbiologic manufacturingfill and finishlinker-payload synthesiscGMP manufacturingbiopharma outsourcinganalytical testingrecombinant protein productionbiotech supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MabPlex International Comparables

Compare MabPlex International with similar companies based on industry and business-model similarity.

MabPlex International comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BiBo Biopharma Engineering Co., Ltd.
88%
Abzena
87%
WuXi Biologics
86%

MabPlex International Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 8, 2020
Series AJan 17, 2019

MabPlex International Investors

Notable investors and investment history

MabPlex International investors
InvestorRounds
德同资本Series B
OrbiMedSeries B
Huajin CapitalSeries B
Sunshine Insurance GroupSeries B
SDIC Venture CapitalSeries A
Horus CapitalSeries B
Shenzhen Capital GroupSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 8, 2020

    $71M round led by Huajin Capital and DeTong Capital.

  • Jan 17, 2019

    $59.1M round led by SDIC Venture Capital and Shenzhen Capital Group

MabPlex International Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MabPlex International Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MabPlex International's valuation, stock price, and market status.

Firmographic Details

HeadquartersYantai
Year Founded2013
Last FundingJun 8, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?